Inhaled iloprost controls pulmonary hypertension after cardiopulmonary bypass

Canadian Journal of Anesthesia

Volumn 49, Issue 9, 2002, Pages 963-967

  Theodoraki, Kassiani ^a   Rellia, Panagiota ^a   Thanopoulos, Apostolos ^a   Tsourelis, Loukas ^b   Zarkalis, Dimitrios ^b   Sfyrakis, Petros ^b   Antoniou, Theophani ^a  

^a Onasis Cardiac Surgery Centre   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ETOMIDATE; FENTANYL; ILOPROST; ISOFLURANE; LORAZEPAM; MIDAZOLAM; MORPHINE; ONDANSETRON; OXYGEN; PANCURONIUM; PROSTACYCLIN DERIVATIVE; VASODILATOR AGENT;

ADULT; AEROSOL; AGED; ARTERIAL PRESSURE; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART RIGHT VENTRICLE FUNCTION; HEMODYNAMIC MONITORING; HUMAN; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; NEBULIZATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; STATISTICAL SIGNIFICANCE;

EID: 0036872844     PISSN: 0832610X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03016884     Document Type: Article

References (11)

1. Stein KL, Breisblatt W, Wolfe C, Gaison T, Hardesty R. Depression and recovery of right ventricular function after cardiopulmonary bypass. Crit Care Med 1990; 18: 1197-200.
2. Barst RJ, Rubin LJ, Long WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334: 296-301.
3. Olschewski H, Ghofrani HA, Schmehl T, et al., for the German PPH Study Group. Inhaled iloprost to treat severe pulmonary hypertension. An uncontrolled trial. German PPH study group. Ann Intern Med 2000; 132: 435-43.
4. Riedel B. The pathophysiology and management of perioperative pulmonary hypertension with specific emphasis on the period following cardiac surgery. Int Anesthesiol Clin 1999; 37: 55-79.
5. Mangano DT. Biventricular function after myocardial revascularization in humans: deterioration and recovery patterns during the first 24 hours. Anesthesiology 1985; 62: 571-7.
6. Hoeper MM, Schwarze M, Ehlerding S, et al. Long-term treatment of primary pulmonary hypertension with aerosolized iloprost, a prostacyclin analogue. N Engl J Med 2000; 342: 1866-70.
7. Haraldsson A, Kieler-Jensen N, Nathorst-Westfelt U, Bergh CH, Ricksten SE. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Chest 1998; 114: 780-6.
8. 2 for acute pulmonary hypertension and right ventricular failure. Anesth Analg 2000; 91: 291-5.
9. 2) is an effective addition to the treatment of pulmonary hypertension and hypoxia in the operating room and intensive care unit. Can J Anesth 2001; 48: 924-9.
10. Hoeper MM, Voelkel NF, Bates TO, et al. Prostaglandins induce vascular endothelial growth factor in a human monocytic cell line and in rat lungs via cAMP. Am J Respir Cell Mol Biol 1997; 17: 748-56.
11. Rubin LJ, Mendoza J, Hood M, et al. Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial. Ann Intern Med 1990; 112: 485-91.